BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 19376791)

  • 1. A label-free quantitative proteomics strategy to identify E3 ubiquitin ligase substrates targeted to proteasome degradation.
    Burande CF; Heuzé ML; Lamsoul I; Monsarrat B; Uttenweiler-Joseph S; Lutz PG
    Mol Cell Proteomics; 2009 Jul; 8(7):1719-27. PubMed ID: 19376791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASB2 targets filamins A and B to proteasomal degradation.
    Heuzé ML; Lamsoul I; Baldassarre M; Lad Y; Lévêque S; Razinia Z; Moog-Lutz C; Calderwood DA; Lutz PG
    Blood; 2008 Dec; 112(13):5130-40. PubMed ID: 18799729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The E3 ubiquitin ligase specificity subunit ASB2beta is a novel regulator of muscle differentiation that targets filamin B to proteasomal degradation.
    Bello NF; Lamsoul I; Heuzé ML; Métais A; Moreaux G; Calderwood DA; Duprez D; Moog-Lutz C; Lutz PG
    Cell Death Differ; 2009 Jun; 16(6):921-32. PubMed ID: 19300455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The E3 ubiquitin ligase specificity subunit ASB2α targets filamins for proteasomal degradation by interacting with the filamin actin-binding domain.
    Razinia Z; Baldassarre M; Bouaouina M; Lamsoul I; Lutz PG; Calderwood DA
    J Cell Sci; 2011 Aug; 124(Pt 15):2631-41. PubMed ID: 21750192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASB2α, an E3 ubiquitin ligase specificity subunit, regulates cell spreading and triggers proteasomal degradation of filamins by targeting the filamin calponin homology 1 domain.
    Razinia Z; Baldassarre M; Cantelli G; Calderwood DA
    J Biol Chem; 2013 Nov; 288(44):32093-105. PubMed ID: 24052262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASB2 is an Elongin BC-interacting protein that can assemble with Cullin 5 and Rbx1 to reconstitute an E3 ubiquitin ligase complex.
    Heuzé ML; Guibal FC; Banks CA; Conaway JW; Conaway RC; Cayre YE; Benecke A; Lutz PG
    J Biol Chem; 2005 Feb; 280(7):5468-74. PubMed ID: 15590664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Filamins but not Janus kinases are substrates of the ASB2α cullin-ring E3 ubiquitin ligase in hematopoietic cells.
    Lamsoul I; Erard M; van der Ven PF; Lutz PG
    PLoS One; 2012; 7(8):e43798. PubMed ID: 22916308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Lys-ϵ-Gly-Gly (diGly) proteomics coupled with inducible RNAi reveals ubiquitin-mediated proteolysis of DNA damage-inducible transcript 4 (DDIT4) by the E3 ligase HUWE1.
    Thompson JW; Nagel J; Hoving S; Gerrits B; Bauer A; Thomas JR; Kirschner MW; Schirle M; Luchansky SJ
    J Biol Chem; 2014 Oct; 289(42):28942-55. PubMed ID: 25147182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrates of the ASB2α E3 ubiquitin ligase in dendritic cells.
    Spinner CA; Uttenweiler-Joseph S; Metais A; Stella A; Burlet-Schiltz O; Moog-Lutz C; Lamsoul I; Lutz PG
    Sci Rep; 2015 Nov; 5():16269. PubMed ID: 26537633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of serine 323 of ASB2α is pivotal for the targeting of filamin A to degradation.
    Zakaria R; Lamsoul I; Uttenweiler-Joseph S; Erard M; Monsarrat B; Burlet-Schiltz O; Moog-Lutz C; Lutz PG
    Cell Signal; 2013 Dec; 25(12):2823-30. PubMed ID: 24044920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying E3 Ligase Substrates With Quantitative Degradation Proteomics.
    Jordan VN; Ordureau A; An H
    Chembiochem; 2023 Aug; 24(16):e202300108. PubMed ID: 37166757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of candidate substrates for the Golgi Tul1 E3 ligase using quantitative diGly proteomics in yeast.
    Tong Z; Kim MS; Pandey A; Espenshade PJ
    Mol Cell Proteomics; 2014 Nov; 13(11):2871-82. PubMed ID: 25078903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The E3 ubiquitin ligase HOIL-1 induces the polyubiquitination and degradation of SOCS6 associated proteins.
    Bayle J; Lopez S; Iwaï K; Dubreuil P; De Sepulveda P
    FEBS Lett; 2006 May; 580(11):2609-14. PubMed ID: 16643902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASB2 is a novel E3 ligase of SMAD9 required for cardiogenesis.
    Min KD; Asakura M; Shirai M; Yamazaki S; Ito S; Fu HY; Asanuma H; Asano Y; Minamino T; Takashima S; Kitakaze M
    Sci Rep; 2021 Nov; 11(1):23056. PubMed ID: 34845242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AHR Regulates NK Cell Migration
    Shin JH; Moreno-Nieves UY; Zhang LH; Chen C; Dixon AL; Linde MH; Mace EM; Sunwoo JB
    Front Immunol; 2021; 12():624284. PubMed ID: 33717133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch-induced Asb2 expression promotes protein ubiquitination by forming non-canonical E3 ligase complexes.
    Nie L; Zhao Y; Wu W; Yang YZ; Wang HC; Sun XH
    Cell Res; 2011 May; 21(5):754-69. PubMed ID: 21119685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
    Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M
    J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C/EBPα for ubiquitin-mediated proteasome degradation.
    Pal P; Lochab S; Kanaujiya JK; Kapoor I; Sanyal S; Behre G; Trivedi AK
    Cell Death Dis; 2013 Apr; 4(4):e590. PubMed ID: 23598402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding cullin-RING E3 biology through proteomics-based substrate identification.
    Harper JW; Tan MK
    Mol Cell Proteomics; 2012 Dec; 11(12):1541-50. PubMed ID: 22962057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic approaches to identify E3 ligase substrates.
    Iconomou M; Saunders DN
    Biochem J; 2016 Nov; 473(22):4083-4101. PubMed ID: 27834739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.